Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium oxybate vs propofol for organ protection in pediatric cardiopulmonary bypass surgery
ChiCTR2400092498Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sodium oxybate in Cardiovascular Malformation (CVM), atrial septal defect (ASD) and Ventricular Septal Defect (VSD) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Acute kidney injury. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
sodium oxybate
03
Conditions
Cardiovascular Malformation (CVM)atrial septal defect (ASD)Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on ChiCTR2400092498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092498.